LETTER TO THE EDITOR
ANCA subclasses in IgG4-related disease and ANCA-associated vasculitis
More details
Hide details
1
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
2
Nephrology, Dialysis, and Transplantation Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
Submission date: 2020-04-21
Acceptance date: 2020-04-21
Publication date: 2020-06-12
Arch Med Sci Civil Dis 2020;5(1):41-43
TOPICS
ABSTRACT
Introduction
IgG4-related disease (IgG4-RD) is a fibro-inflammatory condition characterized by fibrotic lesions with lymphoplasmacytic infiltration in one or more organs. Differential diagnosis from ANCA-associated vasculitis (AAV) can be difficult and AAV-IgG4-RD overlap has been reported. Anti-neutrophil cytoplasm antibodies (ANCA) are a hallmark of AAV and ANCA of IgG4 subclass have been detected in AAV-IgG4-RD overlap, but the role of IgG4 ANCA in differentiating AAV and IgG4-RD is presently unclear.
Material and methods
Anti-myeloperoxidase antibodies of each IgG subclass were detected by ELISA in 20 IgG4-RD ANCA-negative patients, in 35 ANCA-MPO+ AAV and in one AAV-IgG4-RD overlap patient.
Results
In the IgG4-RD cohort, 7 patients are positive for at least one ANCA-MPO subclass, but antibody amounts are very low compared to AAV. In the AAV-IgG4-RD overlap patient, only IgG2-ANCA and IgG3-ANCA are detected. AAV patients in the active phase of the disease present higher amounts of IgG4 ANCA-MPO; on the contrary, ANCA-MPO subclass-positive IgG4-RD patients do not display a higher disease activity. In AAV patients, co-expression of more than one ANCA-MPO subclass is associated with higher disease activity, while no such relation can be established in IgG4-RD.
Conclusions
Evaluation of ANCA subclasses does not help in phenotyping IgG4-RD patients. The lack of correlation with disease activity in IgG4-RD and the distribution of ANCA subclasses in the overlap patient suggest that ANCA-MPO do not play a major role in IgG4-RD.
REFERENCES (11)
1.
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539-51.
2.
Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol Mech Dis 2014; 9: 315-47.
3.
Rzepecka A, Babińska A, Sworczak K. IgG4-related disease in endocrine practice. Arch Med Sci 2019; 15: 55-64.
4.
Della-Torre E, Lanzillotta M, Campochiaro C, et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease. Medicine 2016; 95: e4633.
5.
Jayne DR, Weetman AP, Lockwood CM. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991; 84: 476-81.
6.
Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage COS. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 2004; 138: 183-92.
7.
Brouer E, Kallenberg CGM, Giessen M, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders. Clin Exp Immunol 2010; 83: 379-86.
8.
Segelmark M, Wieslander J. IgG subclasses of antineutrophil cytoplasm autoantibodies (anca). Nephrol Dial Transplant 1993; 8: 696-702.
9.
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012; 22: 21-30.
10.
Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD responder index. Int J Rheumatol 2012; 2012: 259408.
11.
Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis 2009; 68: 1827-32.